Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2014; 20(19): 5826-5838
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5826
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5826
Table 1 Clinical characteristics of individuals enrolled in the study n (%)
| Clinical characteristics | HCC number | Control number |
| Age at baseline, years | ||
| ≥ 60 | 20 (32.3) | 6 (27.3) |
| < 60 | 42 (67.7) | 16 (72.7) |
| Median | 55 | 51 |
| Range | 29-76 | 20-72 |
| Sex | ||
| Male | 53 (85.5) | 11 (50.0) |
| Female | 9 (14.5) | 11 (50.0) |
| KPS score | ||
| > 80 | 31 (50.0) | 22 (100.0) |
| 60-80 | 31 (50.0) | 0 (0.0) |
| Hepatitis infection | ||
| HBV positive | 59 (95.2) | 7 (31.2) |
| HBV negative | 3 (4.8) | 15 (68.2) |
| Tumor size (cm) | NA | |
| ≤ 3.0 | 21 (33.9) | |
| > 3.0 | 41 (66.1) | |
| Primary foci | NA | |
| Single | 54 (87.1) | |
| Multiple | 8 (12.9) | |
| Carcinoma cell embolus | NA | |
| Yes | 1 (1.6) | |
| No | 61 (98.4) | |
| AJCC stage at enrollment | NA | |
| Early (stage 1 + 2) | 55 (88.7) | |
| Late (stage 3 + 4) | 7 (11.3) |
- Citation: Mu H, Lin KX, Zhao H, Xing S, Li C, Liu F, Lu HZ, Zhang Z, Sun YL, Yan XY, Cai JQ, Zhao XH. Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry. World J Gastroenterol 2014; 20(19): 5826-5838
- URL: https://www.wjgnet.com/1007-9327/full/v20/i19/5826.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i19.5826